Trinity Biotech | TRIB - Ebitda


Trinity Biotech reported $-9.6M in EBITDA for its fiscal quarter ending in December of 2024.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Bayer EUR 1.62B 529M Sep/2026
Bio-Rad Laboratories USD 119.9M 475.4M Sep/2026
EDAP TMS EUR -6.47M 1.54M Mar/2026
J&J USD 8.99B 721M Jun/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 13.43B 744M Jun/2026
Siemens EUR 4.2B 644M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Tosoh JPY 39.13B 286M Dec/2024
Trinity Biotech USD -9.6M 7.64M Dec/2024
Veracyte USD 41.24M 2.72M Sep/2026